Forendo Pharma receives EUR 4 million in funding

September 7, 2018

The Finnish drug development company Forendo Pharma has raised four million euros from Vesalius Biocapital III Partners. The funding will be used to further develop Forendo’s portfolio of women’s health solutions.

Oriola wins dose dispensing contract in Sweden

August 10, 2018

Finnish company Oriola has signed an agreement with the Stockholm County Council (SLL) to engage in dose dispensing co-operation starting in February 2019.

Biohit GastroPanel finds Korean distributer

February 19, 2018

Finnish biotechology company Biohit and Dow BioMedica have signed an agreement for the distribution of Biohit GastroPanel in Korea.

Orion and Peptonic partner up for health

December 21, 2017

Finnish Orion and Swedish Peptonic Medical have announced a tech transfer agreement for VagiVital, a product set to be launched next year.

Nexstim goes commercial with new funding

October 26, 2017

Medical technology company Nexstim is raising 1.75 million euros in equity financing via a directed issue of new shares to a UK-based fund.

FIT Biotech dives into genes with Avacta

October 5, 2017

FIT Biotech has initiated a research collaboration with UK-based Avacta Group to develop gene therapies combining the companies’ strengths.

Herantis Pharma lands Nordic Stars Award

September 19, 2017

Finnish Herantis Pharma was announced as the winner of the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden.

Herantis Pharma granted a US patent

May 23, 2017

The United States Patent and Trademark Office has issued a patent titled ‘Neurotrophic factor MANF and uses thereof’ to Finnish Herantis Pharma.

Helsinki institutions team up abroad for health

April 21, 2017

The Hospital District of Helsinki and Uusimaa (HUS) and the University of Helsinki are collaborating with Pfizer and GlaxoSmithKline through new partner contracts.

FIT Biotech and InnaVirVax to fight HIV

December 19, 2016

Finnish FIT Biotech and Paris-based InnaVirVax have commenced collaboration in HIV treatment that combines their proprietary immunotherapeutic HIV vaccines.

Orion and US university partner up against cancer

December 15, 2016

Finnish pharmaceutical and diagnostics company Orion has announced a collaboration with a US non-profit organisation in pursuit of new medicines for oncological diseases.